Medtech counterfeiting on LatAm agenda as Brazil prepares Mercosur presidency
This article was originally published in Clinica
Executive Summary
Tackling medtech and pharma counterfeit products is a leading healthcare-related priority for Latin America’s Mercosur group of nations, the Brazilian health ministry has said as it prepares to take over the bloc’s rotating six-month presidency.